Citation only
via OpenAlex
INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Ronald P. Danis, Thomas A. Ciulla, WAYNE ANLIKER LINDA M. PRATT
Retina · 2000 · ▲ 423 citations
Abstract
PURPOSE: To evaluate the efficacy of indocyanine green angiography (ICGA)-guided laser photocoagulation in eyes with fluorescein angiographic evidence of occult choroidal neovascularization (O-CNV) in patients with age-related macular degeneration (ARMD) with or without pigment epithelium detachment (PED). METHODS: Eighty eyes of 79 consecutive patients with O-CNV underwent laser treatment of a clearly outlined extrafoveal ICGA hyperfluorescent area, presumed to be focal CNV. Four types of presumed CNV were treated: Group 1 (20 eyes), CNV beneath the PED; Group 2 (23 eyes), CNV at the margin of the PED; Group 3 (10 eyes), parapapillary CNV and PED; and Group 4 (27 eyes), macular CNV without PED. Median follow-up was 17.5 months (range, 6-24 months). RESULTS: After 1 year, 15% of the eyes in Group 1, 30% in Group 2, 100% in Group 3, and 52% in Group 4 had obliteration of the presumed CNV. After 1 year, visual acuity was stable or improved in 18% of Group 1, in 37.5% of Group 2, in 100% of Group 3, and in 73% of Group 4. The remaining eyes worsened. CONCLUSIONS: Indocyanine green angiography-guided laser treatment may improve or stabilize visual acuity in some eyes with O-CNV. The best outcome is seen in eyes with presumed parapapillary CNV, probably made up of choroidal telangiectases in many cases. The type and location of the presumed CNV influence prognosis after laser treatment considerably. A randomized, controlled clinical study appears necessary to investigate the efficacy of ICGA-guided laser treatment in different types of presumed CNV. The inclusion criteria for further trials need to be defined with precision, as data from patients with different choroidal vascular abnormalities have been pooled until now.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/00006982-200003000-00004
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Danis, R.P., Ciulla, T.A., & PRATT, W.A.L.M. (2000). INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION. <em>Retina</em>. https://doi.org/10.1097/00006982-200003000-00004
Vancouver
Danis RP, Ciulla TA, PRATT WALM. INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION. Retina. 2000. doi:10.1097/00006982-200003000-00004.
BibTeX
@article{ronald2000INTRAV,
title = {INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION},
author = {Ronald P. Danis and Thomas A. Ciulla and WAYNE ANLIKER LINDA M. PRATT},
journal = {Retina},
year = {2000},
doi = {10.1097/00006982-200003000-00004},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Grifols Therapeutics LLC 2004
Open access · US-GOV
Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-C, 10% Treatment in Subjects With Pure Occult Choroidal Neovascularization Due to Age Related Macular Degeneration
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 2010
Open access · US-GOV
Efficacy of Ranibizumab Treatment Every 2 Month Compared to Treatment on Demand on Patients With Choroidal Neo-vascularization (CNV) as a Consequence of Age-related Macular Degeneration (AMD)
Control Delivery Systems 2001
Open access · US-GOV
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
British Journal of Ophthalmology 2003
Open access · OA
Intravitreal triamcinolone acetonide for exudative age related macular degeneration
Archives of Ophthalmology 1993
Citation only
Laser Photocoagulation of Subfoveal Neovascular Lesions of Age-Related Macular Degeneration
Oklahoma State University Center for Health Sciences 2007
Open access · US-GOV